Milestone Scientific Stock Performance
| MLSS Stock | USD 0.88 0 0.13% |
The company secures a Beta (Market Risk) of 1.0, which conveys possible diversification benefits within a given portfolio. Milestone Scientific returns are very sensitive to returns on the market. As the market goes up or down, Milestone Scientific is expected to follow. At this point, Milestone Scientific has a negative expected return of -0.11%. Please make sure to verify Milestone Scientific's maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Milestone Scientific performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Milestone Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
Last Split Factor 1:3 | Last Split Date 2004-01-14 |
1 | Onco-Innovations Announces Appointment of Professor Steven Jones as Senior Scientific Advisor, ... | 05/22/2025 |
2 | Jeff Jochims Appointed Executive Chair at Genesee Scientific | 05/28/2025 |
3 | Pfizer Exceeds Sales Milestone With Cresemba In Asia Pacific And China | 06/05/2025 |
4 | Disposition of 30100 shares by Bp4 S.r.l. of Milestone Scientific at 0.9094 subject to Rule 16b-3 | 06/10/2025 |
5 | T Scientific Co.,Ltd. Stock Rockets 25 percent But Many Are Still Ignoring The Company | 06/11/2025 |
6 | Ivy Asset Groups Evergreen Fund Achieves 100 Million AUM Milestone | 06/12/2025 |
7 | Why the Market Dipped But Boston Scientific Gained Today | 06/13/2025 |
8 | TON Moves Past 3 Milestone on High Trading Volume | 06/16/2025 |
9 | Spine Surgeon Dr. Michael Gallizzi of The Steadman Clinic Achieves Milestone in Robotic and Endoscopic Surgery | 06/18/2025 |
| Begin Period Cash Flow | 3 M | |
| Free Cash Flow | -2.9 M |
Milestone | Build AI portfolio with Milestone Stock |
Milestone Scientific Relative Risk vs. Return Landscape
If you would invest 101.00 in Milestone Scientific on March 22, 2025 and sell it today you would lose (13.11) from holding Milestone Scientific or give up 12.98% of portfolio value over 90 days. Milestone Scientific is currently does not generate positive expected returns and assumes 4.722% risk (volatility on return distribution) over the 90 days horizon. In different words, 42% of stocks are less volatile than Milestone, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Milestone Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Milestone Scientific's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Milestone Scientific, and traders can use it to determine the average amount a Milestone Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0241
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MLSS |
Estimated Market Risk
| 4.72 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Milestone Scientific is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Milestone Scientific by adding Milestone Scientific to a well-diversified portfolio.
Milestone Scientific Fundamentals Growth
Milestone Stock prices reflect investors' perceptions of the future prospects and financial health of Milestone Scientific, and Milestone Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Milestone Stock performance.
| Return On Equity | -0.88 | ||||
| Return On Asset | -0.45 | ||||
| Profit Margin | (0.61) % | ||||
| Operating Margin | (0.89) % | ||||
| Current Valuation | 67.09 M | ||||
| Shares Outstanding | 78.48 M | ||||
| Price To Earning | (6.39) X | ||||
| Price To Book | 15.47 X | ||||
| Price To Sales | 8.01 X | ||||
| Revenue | 8.63 M | ||||
| Gross Profit | 6.41 M | ||||
| EBITDA | (6.72 M) | ||||
| Net Income | (4.71 M) | ||||
| Cash And Equivalents | 9.81 M | ||||
| Cash Per Share | 0.14 X | ||||
| Total Debt | 349.05 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 3.95 X | ||||
| Book Value Per Share | 0.06 X | ||||
| Cash Flow From Operations | (2.92 M) | ||||
| Earnings Per Share | (0.06) X | ||||
| Market Capitalization | 69.02 M | ||||
| Total Asset | 9.8 M | ||||
| Retained Earnings | (128.05 M) | ||||
| Working Capital | 5.54 M | ||||
| Current Asset | 10.74 M | ||||
| Current Liabilities | 4.4 M | ||||
About Milestone Scientific Performance
Assessing Milestone Scientific's fundamental ratios provides investors with valuable insights into Milestone Scientific's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Milestone Scientific is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 617.36 | 648.23 | |
| Return On Tangible Assets | (0.49) | (0.51) | |
| Return On Capital Employed | (1.12) | (1.17) | |
| Return On Assets | (0.48) | (0.51) | |
| Return On Equity | (0.81) | (0.85) |
Things to note about Milestone Scientific performance evaluation
Checking the ongoing alerts about Milestone Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Milestone Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Milestone Scientific generated a negative expected return over the last 90 days | |
| Milestone Scientific has some characteristics of a very speculative penny stock | |
| Milestone Scientific has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 8.63 M. Net Loss for the year was (4.71 M) with profit before overhead, payroll, taxes, and interest of 6.41 M. | |
| Milestone Scientific currently holds about 9.81 M in cash with (2.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14. | |
| Milestone Scientific has a frail financial position based on the latest SEC disclosures | |
| Roughly 22.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Spine Surgeon Dr. Michael Gallizzi of The Steadman Clinic Achieves Milestone in Robotic and Endoscopic Surgery |
- Analyzing Milestone Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Milestone Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Milestone Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Milestone Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Milestone Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Milestone Scientific's stock. These opinions can provide insight into Milestone Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Milestone Stock Analysis
When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.